Learning & Memory · 2014 · 32 citations · 23 references
MedicineNeurosciencePharmacologyMemoryNeuropharmacologyPsychopharmacologyAnxiety Disorder PharmacotherapyAnxiety DisordersAnxiolytic PharmacologyAnxiolytic PharmacotherapyFear CircuitsPsychotherapy For Anxiety DisordersAllosteric Modulator BindingContextual Fear MemoryExposure TherapyExposure-based TherapyMetabotropic Glutamate Receptor SignalingPharmacological TherapySystemic AdministrationTreatment Of Anxiety Disorders
Behavioral exposure therapy, which involves extinction of the previously acquired fear, has been used to treat anxiety-related symptoms such as post-traumatic stress disorder. It has been hypothesized that proextinction pharmacotherapeutics may enhance the efficacy of exposure therapy. Systemic administration of the metabotropic glutamate receptor 5 (mGluR5)-positive allosteric modulator 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) facilitated the extinction of contextual fear memory. Notably, CDPPB also enhanced the initial fear memory formation, and had no effect on memory retrieval. Our data suggest that positive regulation of mGluR5 may offer a new method to enhance exposure therapy through facilitating extinction without adversely affecting other aspects of memory process.
23
Genetic enhancement of learning and memory in mice
Ya‐Ping Tang, Eiji Shimizu, Gilles Dubé et al. · Nature · 1999 · 1.9K citations
Ted Abel, Peter Nguyen, Mark Barad et al. · Cell · 1997 · 1.2K citations · Full text
Hazar Awad, George W. Hubert, Yoland Smith et al. · Journal of Neuroscience · 2000 · 420 citations · Full text
D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder
Matt G. Kushner, Suck Won Kim, Christopher B. Donahue et al. · Biological Psychiatry · 2007 · 386 citations